Development of framework for QHC

• October, 2000: FDA revoked the regulation codifying its decision to not authorize 4 claims that were the subject of the Pearson case.
• Court decisions:
• Qualified Health Claims were subsequently allowed through enforcement discretion for antioxidant vitamins, 0.8 mg of folic acid, B-vitamins and vascular disease.
• QHCs reviewed before implementing the 2003 interim procedures
• Omega-3 fatty acids and heart disease for dietary supplements
• Selenium and cancer
• Nuts and heart disease
• Walnuts and heart disease
• Phosphatidylserine and cognitive dysfunction and dementia